Search

Filters
Clear All
  • 14
  • 47
  • 1
  • 635

Phase

  • 18
  • 17
  • 51
  • 5
  • 74
  • 5
  • 520
  • 620
  • 284
  • 685
  • 12

Found 697 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 HAVE YOU RECENTLY TESTED POSITIVE FOR COVID? Help Us Test a New Treatment for Covid!
J
James Chmiel
M
Mike Davis
18 years - 60 years
Accepts healthy volunteer
All genders
Researchers at Indiana University School of Medicine are researching a nasal treatment for COVID-19. We are looking for people with a recent onset of mild COVID-19 symptoms and a positive COVID-19 test in the last few days to come for a 2 hour visit at Riley Hospital for Children to help …
 VOLUNTEERS AGES 21-26 NEEDED FOR ALCOHOL AND BRAIN IMAGING STUDY!
D
David Kareken, PhD
21 years - 27 years
Accepts healthy volunteer
All genders
Do you drink alcohol? If yes, we want to learn about your brain activity! Researchers at the IU School of Medicine are looking for volunteers aged 21-27 to participate in an alcohol and brain imaging study.. To learn more about the Principal Investigator David Kareken, PhD and his research interests, …
L
Lisa Landrum, MD, PhD, MS
18 years or above
Female
Phase 3
Interventional
This study investigates treatments for women with platinum-resistant epithelial ovarian cancer, which is a type of cancer that does not respond to platinum-based chemotherapy. The purpose is to compare the effects of different treatments, including an investigational medication called nemvaleukin, either alone or in combination with another treatment, pembrolizumab, against …
N
Naoyuki Saito, MD
50 years - 70 years
All genders
Phase 3
Interventional
This study investigates the treatment of breast cancer in patients who have hormone-sensitive, HER-2 negative tumors with a low recurrence score. The purpose is to understand if breast conservation surgery with only endocrine therapy is as effective as combining it with radiation therapy in preventing the return of cancer in …
S
Scott Goebel, MD
1 month - 79 years
All genders
Phase 2
Interventional
What is the purpose of this study?Related donor Epstein-Barr Virus (EBV) specific cytotoxic T cells (CTLs) manufactured withhe Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children,dolescents and young adults with refractory EBV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid …
S
Scott Goebel, MD
1 month - 79 years
All genders
Phase 1/2
Interventional
What is the purpose of this study?BK cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Captureystem will be safe and effective in decreasing specific viral load in children, adolescents and young adults (CAYA) with refractory BK infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) or with primary …
S
Scott Goebel, MD
1 month - 79 years
All genders
Phase 2
Interventional
What is the purpose of this study?Related donor Adenovirus (ADV) specific cytotoxic T cells (CTLs) manufactured with theyi CliniMACS Prodigy Cytokine Capture System will be administered intravenously in inhildren, adolescents and young adults with refractory ADV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) ord organ …
S
Scott Goebel, MD
1 month - 30 years
All genders
Phase 2
Interventional
What is the purpose of this study?CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) with refractory cytomegalovirus (CMV) infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ …
P
Phuongthao Quan
18 years - 100 years
All genders
Phase 3
Interventional
What is the purpose of this study?This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive treatment in adult subjects diagnosed with generalized epilepsy and experiencing probable or possible PGTCS (with or without other subtypes of generalized …
B
Beatrice Stefanescu
10 hours or below
All genders
Phase 2
Interventional
What is the purpose of this study?Hypoxic-ischemic encephalopathy (HIE) affects approximately 4,000 to 12,000 persons annually in the United States. Mortality from HIE has been reported up to 60%, with at least 25% of survivors left with significant neurocognitive disability. Despite this vital unmet medical need, no pharmacological adjunct or …
11 - 20 of 697